Cargando…
Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy
GM1 gangliosidosis is a fatal lysosomal disorder, for which there is no effective treatment. Adeno-associated virus (AAV) gene therapy in GM1 cats has resulted in a greater than 6-fold increase in lifespan, with many cats remaining alive at >5.7 years of age, with minimal clinical signs. Glycolip...
Autores principales: | Gray-Edwards, Heather L., Jiang, Xuntian, Randle, Ashley N., Taylor, Amanda R., Voss, Taylor L., Johnson, Aime K., McCurdy, Victoria J., Sena-Esteves, Miguel, Ory, Daniel S., Martin, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545771/ https://www.ncbi.nlm.nih.gov/pubmed/28808666 http://dx.doi.org/10.1016/j.omtm.2017.07.005 |
Ejemplares similares
-
AAV-Mediated Gene Delivery in a Feline Model of Sandhoff Disease Corrects Lysosomal Storage in the Central Nervous System
por: Rockwell, Hannah E., et al.
Publicado: (2015) -
Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease
por: McCurdy, Victoria J., et al.
Publicado: (2020) -
7T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy
por: Gray-Edwards, Heather L., et al.
Publicado: (2019) -
Topics in Feline Neurology
por: Nafe, Larry A.
Publicado: (1984) -
Towards a New Diagnostic Standard for Niemann–Pick C Disease
por: Jiang, Xuntian, et al.
Publicado: (2016)